Research and Development

Pfizer boasts the industry's largest pharmaceutical R&D organization: Pfizer Global Research and Development. More than 12,400 scientists work in Pfizer research facilities around the world, keeping its quest alive and well.

Our investment in R&D into new and better medicines involves both our hearts and minds. Employing state-of-the-art tools ranging from robotic high-throughput screening to sophisticated genomic studies, our scientists and technicians deliver innovative new products and prescription medicines to effectively treat disease and enhance human and animal life.

Moving forward, our scientists will continue their search for new medicines and cures for diseases like atypical pneumonia, Alzheimer's, diabetes and cancer.

Today's Pfizer has more new medicines under development than any other company, with over 200 research projects already underway.

To know more, please visit http://www.pfizer.com/research